KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma

Amandine Decroos, Morgane Cheminant, Julie Bruneau, Sylvain Carras, Vincent Parinet, Laura Pelletier, Laetitia Lacroix, Nadine Martin, Jérôme Giustiniani, Ludovic Lhermitte, Vahid Asnafi, Maxime Battistella, François Lemonnier, Laurence De Leval, Hélène Sicard, Cécile Bonnafous, Laurent Gauthier, Laurent Genestier, Stefano Caruso, Philippe Gaulard, Olivier Hermine, Nicolas Ortonne

Open source

DOI: 10.3324/haematol.2022.282220
Published: 2023-05-11
Container: Haematologica
Publisher: Ferrata Storti Foundation (Haematologica)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2022.282220,
  title = {KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma},
  author = {Amandine Decroos and Morgane Cheminant and Julie Bruneau and Sylvain Carras and Vincent Parinet and Laura Pelletier and Laetitia Lacroix and Nadine Martin and Jérôme Giustiniani and Ludovic Lhermitte and Vahid Asnafi and Maxime Battistella and François Lemonnier and Laurence De Leval and Hélène Sicard and Cécile Bonnafous and Laurent Gauthier and Laurent Genestier and Stefano Caruso and Philippe Gaulard and Olivier Hermine and Nicolas Ortonne},
  year = {2023},
  journal = {Haematologica},
  doi = {10.3324/haematol.2022.282220},
  url = {https://doi.org/10.3324/haematol.2022.282220}
}

RIS

TY  - JOUR
TI  - KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma
AU  - Amandine Decroos
AU  - Morgane Cheminant
AU  - Julie Bruneau
AU  - Sylvain Carras
AU  - Vincent Parinet
AU  - Laura Pelletier
AU  - Laetitia Lacroix
AU  - Nadine Martin
AU  - Jérôme Giustiniani
AU  - Ludovic Lhermitte
AU  - Vahid Asnafi
AU  - Maxime Battistella
AU  - François Lemonnier
AU  - Laurence De Leval
AU  - Hélène Sicard
AU  - Cécile Bonnafous
AU  - Laurent Gauthier
AU  - Laurent Genestier
AU  - Stefano Caruso
AU  - Philippe Gaulard
AU  - Olivier Hermine
AU  - Nicolas Ortonne
PY  - 2023
JO  - Haematologica
DO  - 10.3324/haematol.2022.282220
UR  - https://doi.org/10.3324/haematol.2022.282220
ER  -

APA

Decroos, A., Cheminant, M., Bruneau, J., Carras, S., Parinet, V., Pelletier, L., Lacroix, L., Martin, N., Giustiniani, J., Lhermitte, L., Asnafi, V., Battistella, M., Lemonnier, F., Leval, L. D., Sicard, H., Bonnafous, C., Gauthier, L., Genestier, L., Caruso, S., Gaulard, P., Hermine, O., & Ortonne, N. (2023). KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma. Haematologica. https://doi.org/10.3324/haematol.2022.282220

Source records

crossref · retrieved 2026-09-27T08:15:01.364Z